Corporate Banner
Satellite Banner
Technology
Networks
Scientific Communities
 
Become a Member | Sign in
Home>Events>This Event
  Events - October 2013


Drug Discovery Re-Invented; Emerging Role of Biotechs, Academics and Non-Profits

16 Oct 2013 - 19 Oct 2013 - Scottsdale, AZ, USA



Bookmark and Share


Poster Submission Deadline: 14-Aug-13
Registration Deadline: 21-Aug-13


The conference will center on new approaches to drug discovery in an industry where the landscape is changing rapidly. With large pharma reducing investment in internal early stage research, drug pipelines will increasingly be filled by alternative sources. These players include: government, academic labs, non-profits, biotech companies, and pharmaceutical “open innovation” models. The conference will also provide examples of successful strategies for advancing new drug candidates in this era of distributed discovery.

The full programme is now available, please see conference website for details!

Key Sessions include:

  1. Discovery Re-Invented
  2. Novel Pharma Approaches
  3. Collaborative Drug Discovery
  4. Natural Products
  5. Structure, Modelling and Informatics
  6. Biologics and Non-traditional Therapeutics
  7. Discovery Technologies

This conference is designed to attract the following attendees: medicinal, computational, and synthetic organic chemists; structural and screening biologists; research management and entrepreneurs; industrial and academic scientists.

Confirmed Speakers:

Prof. William Jorgensen (Plenary), Yale University
Prof. Jef De Brabander, UT Southwestern Medical
Dr. Bart DeCorte, Janssen Research & Development
Prof. James Barrow, Johns Hopkins School of Medicine
Dr. Ken Duncan (Plenary), Bill & Melinda Gates Foundation
Dr. Guy Breitenbucher, Dart Neuroscience
Dr. Barry Bunin, Collaborative Drug Discovery
Dr. Paul Labute, Chemical Computing Group
Dr. Leah Frye, Schrodinger
Prof. Sean Brady, The Rockefeller University
Dr. Steven Young (Plenary), BeiGene
Dr. Craig Thomas, NIH Chemical Genomics Center
Dr. Michael Trzoss, Trius Therapeutics
Dr. Joseph Vacca, WuXi AppTec
Dr. Michael Goetz, Natural Products Discovery Institute
Prof. George Georgiou, The University of Texas at Austin
Dr. Benjamin Blass, Temple University School of Pharmacy
Prof. Kenneth Merz, University of Florida
Dr. Michael Foley (Plenary), Broad Institute
Dr. David Gorenstein, University of Texas HSC Houston
Dr. Zhengying Pan, Peking University, Shenzhen Graduate School
Dr. Andreas G. Bader, Mirna Therapeutics
Dr. Todd Chappell, NIH and BioHealth Innovation
Dr. Trevor Hallam, Sutro Biopharma
Dr. Patrick Lam, Lam Drug Discovery Consulting
Dr. Sandhya Kortagere, Drexel University College of Medicine
Dr. Mark McDonnell, Fox Chase Chemical Diversity Center
Dr. Serge L Boulet, Eli Lilly
Dr. Gabor Butora, Merck
Dr. Janet L. Ralbovsky, University of Tennessee Research Foundation
Dr. Paul Leeson, GlaxoSmithKline
Dr. Matthew Segall, Optibrium Ltd.
Dr. Guy Carter, Biosortia Pharmaceuticals
Dr. Chris Williams, Chemical Computing Group

Poster Submission Deadline: 14-Aug-13
Registration Deadline: 21-Aug-13



Further information
Scientific News
NIH Study Finds Calorie Restriction Lowers Some Risk Factors for Age-Related Diseases
Two-year trial did not produce expected metabolic changes, but influenced other life span markers.
Immunotherapy Agent Benefits Patients with Drug-Resistant Multiple Myeloma in First Human Trial
Daratumumab proved generally safe in patients, even at the highest doses.
Low-level Arsenic Exposure Before Birth Associated with Early Puberty in Female Mice
Study examine whether low-dose arsenic exposure could have similar health outcomes in humans.
Inciting an Immune Attack On Cancer Cells
A new minimally invasive vaccine that combines cancer cells and immune-enhancing factors could be used clinically to launch a destructive attack on tumors.
‘Mutation-Tracking’ Blood Test for Breast Cancer
Scientists have developed a blood test for breast cancer able to identify which patients will suffer a relapse after treatment, months before tumours are visible on hospital scans.
Cellular Contamination Pathway for Heavy Elements Identified
Berkeley Lab scientists find that an iron-binding protein can transport actinides into cells.
Intensity of Desert Storms May Affect Ocean Phytoplankton
MIT study finds phytoplankton are extremely sensitive to changing levels of desert dust.
Common ‘Heart Attack’ Blood Test May Predict Future Hypertension
Small rises in troponin levels may have value as markers for subclinical heart damage and high blood pressure.
LaVision BioTec Reports on the Neuro Research on the Human Brain After Trauma
Company reports on the work of Dr Ali Ertürk from the Institute for Stroke and Dementia Research at LMU Munich.
NIH Study Shows No Benefit of Omega-3 Supplements for Cognitive Decline
Research was published in the Journal of the American Medical Association.
Scroll Up
Scroll Down
Skyscraper Banner

Skyscraper Banner
Go to LabTube
Go to eposters
 
Access to the latest scientific news
Exclusive articles
Upload and share your posters on ePosters
Latest presentations and webinars
View a library of 1,800+ scientific and medical posters
2,500+ scientific and medical posters
A library of 2,500+ scientific videos on LabTube
3,800+ scientific videos
Close
Premium CrownJOIN TECHNOLOGY NETWORKS PREMIUM FREE!